Fig. 3From: Development of highly efficient niosomal systems for co-delivery of drugs and genes to treat breast cancer in vitro and in vivoObtained stability of formulation of Cur (Fc4, Fc5, Fc6) according to a PDI test, b size, c zeta, and d EE%. e Synthesis of cationic miRNA-loaded niosomal complexes and f their time-dependent stabilityBack to article page